BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 16392139)

  • 1. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
    Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. I. Preparation and characterization.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):283-92. PubMed ID: 15227673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites.
    Hedberg EL; Tang A; Crowther RS; Carney DH; Mikos AG
    J Control Release; 2002 Dec; 84(3):137-50. PubMed ID: 12468217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
    Hedberg EL; Shih CK; Lemoine JJ; Timmer MD; Liebschner MA; Jansen JA; Mikos AG
    Biomaterials; 2005 Jun; 26(16):3215-25. PubMed ID: 15603816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere/poly(propylene fumarate) composite.
    Kempen DH; Kruyt MC; Lu L; Wilson CE; Florschutz AV; Creemers LB; Yaszemski MJ; Dhert WJ
    Tissue Eng Part A; 2009 Mar; 15(3):587-94. PubMed ID: 18925831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Dimension-Printed Porous Poly(Propylene Fumarate) Scaffolds with Delayed rhBMP-2 Release for Anterior Cruciate Ligament Graft Fixation.
    Parry JA; Olthof MG; Shogren KL; Dadsetan M; Van Wijnen A; Yaszemski M; Kakar S
    Tissue Eng Part A; 2017 Apr; 23(7-8):359-365. PubMed ID: 28081675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different sustained bone morphogenetic protein-2 release kinetics on bone formation in poly(propylene fumarate) scaffolds.
    Olthof MGL; Kempen DHR; Herrick JL; Yaszemski MJ; Dhert WJA; Lu L
    J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):477-487. PubMed ID: 28186684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone regeneration using a microstereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres.
    Lee JW; Kang KS; Lee SH; Kim JY; Lee BK; Cho DW
    Biomaterials; 2011 Jan; 32(3):744-52. PubMed ID: 20933279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicomechanical properties of sintered scaffolds formed from porous and protein-loaded poly(DL-lactic-co-glycolic acid) microspheres for potential use in bone tissue engineering.
    Boukari Y; Scurr DJ; Qutachi O; Morris AP; Doughty SW; Rahman CV; Billa N
    J Biomater Sci Polym Ed; 2015; 26(12):796-811. PubMed ID: 26065672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering.
    Boukari Y; Qutachi O; Scurr DJ; Morris AP; Doughty SW; Billa N
    J Biomater Sci Polym Ed; 2017 Nov; 28(16):1966-1983. PubMed ID: 28777694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres.
    Song K; Liu Y; Macedo HM; Jiang L; Li C; Mei G; Liu T
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1506-13. PubMed ID: 23827602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles.
    FĂ©lix Lanao RP; Leeuwenburgh SC; Wolke JG; Jansen JA
    Biomaterials; 2011 Dec; 32(34):8839-47. PubMed ID: 21871661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics.
    Habraken WJ; Wolke JG; Mikos AG; Jansen JA
    J Biomater Sci Polym Ed; 2008; 19(9):1171-88. PubMed ID: 18727859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of porous injectable poly-(propylene fumarate)-based bone graft substitute.
    Kim CW; Talac R; Lu L; Moore MJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2008 Jun; 85(4):1114-9. PubMed ID: 17941027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
    Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
    J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
    Hedberg EL; Kroese-Deutman HC; Shih CK; Crowther RS; Carney DH; Mikos AG; Jansen JA
    Biomaterials; 2005 Aug; 26(22):4616-23. PubMed ID: 15722131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication and characterization of poly(propylene fumarate) scaffolds with controlled pore structures using 3-dimensional printing and injection molding.
    Lee KW; Wang S; Lu L; Jabbari E; Currier BL; Yaszemski MJ
    Tissue Eng; 2006 Oct; 12(10):2801-11. PubMed ID: 17518649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro.
    Lu HH; El-Amin SF; Scott KD; Laurencin CT
    J Biomed Mater Res A; 2003 Mar; 64(3):465-74. PubMed ID: 12579560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.
    Kempen DH; Lu L; Hefferan TE; Creemers LB; Maran A; Classic KL; Dhert WJ; Yaszemski MJ
    Biomaterials; 2008 Aug; 29(22):3245-52. PubMed ID: 18472153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.